SCHEMBL4101951

SCHEMBL4101951

CCCCOc1cccc(C(=O)O)c1C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
KDM4E B2RXH2 1/20 0.51
RECQL P46063 1/20 0.51
NR1I2 O75469 1/20 0.51
LMNA P02545 1/20 0.51
CHRM2 P08172 1/20 0.51
CYP3A4 P08684 1/20 0.51
ADRA2A P08913 1/20 0.51
MAPT P10636 1/20 0.51
OPRK1 P41145 1/20 0.51
HTR2B P41595 1/20 0.51
SLC6A3 Q01959 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
ALDH1A1 P00352 2/20 0.50
PTK2B Q14289 1/20 0.50
PTPN11 Q06124 2/20 0.49
PTGER1 P34995 1/20 0.49
ALOX5 P09917 2/20 0.48
WDR5 P61964 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orziloben SCHEMBL6531935 0.95 MEN1 (0.57) KMT2AMEN1KDM4ERECQLNR1I2
Orziloben SCHEMBL23748710 0.94 MEN1 (0.56) KMT2AMEN1NR1I2LMNACHRM2
SCHEMBL20503229 0.94 MEN1 (0.60) KMT2AMEN1NR1I2LMNACHRM2
SCHEMBL23748668 0.94 MEN1 (0.60) KMT2AMEN1NR1I2LMNACHRM2
Orziloben SCHEMBL23748623 0.94 MEN1 (0.56) KMT2AMEN1NR1I2LMNACHRM2
Orziloben SCHEMBL28616001 0.94 MEN1 (0.56) KMT2AMEN1NR1I2LMNACHRM2
SCHEMBL2340348 0.92 KMT2A (0.51) KMT2AMEN1KDM4ERECQLNR1I2
SCHEMBL25289272 0.90 ALDH1A1 (0.53) KMT2AMEN1NR1I2LMNACHRM2
SCHEMBL11418287 0.85 ALDH1A1 (0.51) KMT2AKDM4ELMNAALDH1A1PTK2B
SCHEMBL2345074 0.85 PTGER1 (0.52) KMT2AMEN1LMNAPTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-53021148-A None JP disclosed
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof BASF AS (NO) 2025-11-18 US disclosed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
EP-3864001-A1 ROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-08-18 EP disclosed
CN-113166024-A Aromatic compounds and their medical use 巴斯夫股份公司 2021-07-23 CN disclosed
US-8501771-B2 Aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments SANOFI (FR) 2013-08-06 US disclosed
US-20090082391-A1 NOVEL AMINOALCOHOL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS SANOFI-AVENTIS (FR) 2009-03-26 US disclosed
JP-S5321148-A STABLE CHOLESTERIC COMPOUND CHISSO CORP 1978-02-27 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof GLS2, FFAR3, SLC10A1 KMT2A 2026/4885MEN1 2226/4885KDM4E 1204/4885
US-20090082391-A1 NOVEL AMINOALCOHOL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS MCHR1, AHR, MCHR2 KMT2A 678/4885MEN1 3044/4885KDM4E 889/4885
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF GLS2, FFAR3, SLC10A1 KMT2A 2026/4885MEN1 2226/4885KDM4E 1204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.